Published on 19 May 2023 on Simply Wall St. via Yahoo Finance
Even if it's not a huge purchase, we think it was good to see that Pankaj Mohan, the Founder of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) recently shelled out US$83k to buy stock, at US$0.22 per share. Even though that isn't a massive buy, it did increase their holding by 149%, which is arguably a good sign.
View our latest analysis for Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings Insider Transactions Over The Last Year